IMMULAB: A Phase II Trial of Immunotherapy with Pembrolizumab in Combination with Local Ablation for Patients with Early Stage Hepatocellular Carcinoma (hcc)—the IKF-IMMULAB Trial.Arndt Vogel,Oliver Waidmann,Thomas Christian Wirth, Mueller Tobias,Raphael Mohr,Gabriele Margareta Siegler,Thorsten O. Goetze, Enrico N. De Toni,Alexander B Philipp,Maria A Gonzalez-Carmona,Guido Hausner,Michael Geissler,Ludwig Fischer von Weikersthal,Angelika Kestler,Fabian Finkelmeier,Jorge Klagges,Regina Eickhoff,Salah-Eddin Al-Batran,Anna Lena SaborowskiJournal of Clinical Oncology（2025）引用 0|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
